ArticlePolicy insights from the behavioral and brain sciences2023
Project Prakash: Merging Basic Science and Societal Service in Vision Research.
Article in Policy insights from the behavioral and brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Motion's privilege in recognizing facial expressions following treatment for blindness.Current biology : CB · 2024Article
- Face-specific identification impairments following sight-providing treatment may be alleviated by an initial period of low visual acuity.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
For nearly 20 years, Prakash has created a humanitarian-scientific synergy by treating congenitally blind children in rural India, then following their visual development to understand how the human brain learns to see. From solving a 300-year-old conundrum to deconstructing the "critical window" of neuroplasticity, Prakash has led to new ways of thinking about development. Unfortunately, many children suffering from treatable congenital blindness around the world remain untreated due to a persistent belief that improvements are not possible past a "critical age" of 5-7 years old. Here, a review of the data identifies an urgent need to engage with stakeholders across the global medical community to disseminate Prakash's findings and overturn these entrenched dogmas. Toward that end, recent partnerships with eye-health organizations expand the reach of this approach and cultivate a cohesive global network. Prakash exemplifies both evidence-based intervention and intervention-based scientific discovery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.